Seven variants of those isoforms were reported and, interestingly, ΔDNMT3B1, ΔDNMT3B2, and ΔDNMT3B4 expression was correlated with CDKN2A (p16) and RASSF1A promoter DNA methylation in tumor cells [136,137]. This evidence concerns the gene CDKN2A and neoplasm.